Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase I/II, open-label, dose escalating study of injectable RT 002 [botulinum toxin A] in patients with moderate to severe glabellar lines

Trial Profile

Phase I/II, open-label, dose escalating study of injectable RT 002 [botulinum toxin A] in patients with moderate to severe glabellar lines

Status: Completed
Phase of Trial: Phase I/II

Latest Information Update: 08 Jan 2015

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Daxibotulinumtoxin A (Primary)
  • Indications Glabellar lines
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 26 May 2014 New trial record
    • 13 May 2014 Positive results from this study were reported in late April 2014, according to a Revance Therapeutics media release.
    • 21 Apr 2014 Results published in the Media Release.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with a username/password associated to your organization’s account.
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Federated access using single sign-on credentials.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top